5:07PM Health Care REIT beats by $0.04; tightens Y08 guidance range (HCN) 51.94 +1.64 : Reports Q2 (Jun) normalized funds from operations of $0.87 per share, $0.04 better than the First Call consensus of $0.83. Co issues in-line guidance for FY08, sees normalized FFO of $3.33-3.39, compared to previous guidance of $3.30-3.38, vs. $3.33 consensus; co affirms investment guidance of $1.1-1.4 bln.
4:59PM InfoSpace beats by $0.07, beats on revs; guides Q3 EPS in-line, revs above consensus; guides FY08 EPS above consensus, revs above consensus (INSP) 8.84 -0.18 : Reports Q2 (Jun) earnings of $0.06 per share, $0.07 better than the First Call consensus of ($0.01); revenues rose 20.6% year/year to $38.3 mln vs the $34.8 mln consensus. Co issues mixed guidance for Q3, sees EPS of ($0.01) to $0.01 vs. $0.00 consensus; sees Q3 revs of $37-39 mln vs. $35.88 mln consensus. Co issues upside guidance for FY08, sees EPS of ($0.01) to $0.03 vs. ($0.02) consensus; sees FY08 revs of $156-160 mln vs. $152.19 mln consensus. "We achieved higher-than-expected revenue and Adjusted EBITDA in the second quarter," said Jim Voelker, chairman and chief executive officer. "Much of our success can be attributed to growth in our owned-and-operated properties, demonstrating the progress the team has made in executing the Company's new initiatives. As we look toward the remainder of the year, we are optimistic about our ability to grow profitably."
4:57PM Titanium Metals reports EPS in-line, misses on revs (TIE) 10.68 +0.70 : Reports Q2 (Jun) earnings of $0.26 per share, in-line with the First Call consensus of $0.26; revenues were unchanged from the year-ago period at $297.3 mln.
4:37PM USEC Inc. beats by $0.10, misses on revs; guides FY08 revs below consensus (USU) 4.97 -0.05 : Reports Q2 (Jun) earnings of $0.10 per share, $0.10 better than the First Call consensus of ($0.00); revenues rose 18.0% year/year to $249 mln vs the $357.6 mln consensus. Co issues downside guidance for FY08, sees FY08 revs of $1.70 bln vs. $1.73 bln consensus. USU also updated and reiterated its annual guidance for 2008 of net income in a range of $25 to $45 mln and cash flow used in operations of $60 to $80 mln.
4:36PM ONEOK Partners beats by $0.42, beats on revs; guides FY08 EPS above consensus (OKS) 52.60 -0.51 : Reports Q2 (Jun) earnings of $1.46 per share, $0.42 better than the First Call consensus of $1.04; revenues rose 55.9% year/year to $2.14 bln vs the $1.51 bln consensus. Co issues upside guidance for FY08, sees EPS of $5.20-5.60 vs. $4.70 consensus. "Strong results in the first half of 2008, combined with the current commodity price environment and hedges in place, have resulted in increased 2008 income and cash flow guidance in the natural gas gathering and processing segment and natural gas liquids gathering and fractionation segment. The natural gas liquids pipelines segment's 2008 income has been adjusted to reflect the previously announced delay of the Overland Pass Pipeline, which is expected to become operational in the third quarter 2008. Additional information is available in exhibits A and B."
4:33PM Charles River beats by $0.06, beats on revs; raises FY08 guidance; boosts buyback to $200 mln (CRL) 66.63 -0.10 : Reports Q2 (Jun) earnings of $0.79 per share, excluding non-recurring items, $0.06 better than the First Call consensus of $0.73; revenues rose 14.5% year/year to $352 mln vs the $344.1 mln consensus. Co raises guidance for FY08, to EPS of $.94-3.00 from $2.87-2.97 vs. $2.97 consensus; co raises FY08 revenue growth guidance to 12-14% from 10-13%. Co also increased its buyback authorization to $200 mln.
4:24PM Plains Exploration beats by $0.23, beats on revs (PXP) 51.83 -0.56 : Reports Q2 (Jun) earnings of $1.84 per share, $0.23 better than the First Call consensus of $1.61; revenues rose 186.8% year/year to $732.7 mln vs the $666.7 mln consensus. PXP reaffirms FY08 operating and financial guidance. As previously announced, oil and gas expenditures for 2008 are expected to be approximately $1.5 bln, excluding acquisitions. Sales volumes increased to 87.5 thousand BOEPD during Q2 from 53.5 thousand BOEPD in the second quarter 2007 reflecting the Pogo acquisition and increased production from the Piceance Basin. PXP expects sales volumes to average between 92-96 mBOEPD for the year-ended 2008 and is currently producing within that range. Flatrock and other growth initiatives are expected to contribute to sales volume growth throughout the year.
4:24PM Herbalife beats by $0.11, beats on revs; guides Q3 EPS in-line; guides FY08 EPS above consensus (HLF) 43.41 -0.42 : Reports Q2 (Jun) earnings of $1.03 per share, $0.11 better than the First Call consensus of $0.92. Co issues in-line guidance for Q3, sees EPS of $0.81-0.84 vs. $0.84 consensus. Co issues upside guidance for FY08, sees EPS of $3.64-3.69 vs. $3.59 consensus.
4:21PM Boston Beer Co beats by $0.01, beats on revs; reaffirms FY08 EPS guidance (SAM) 43.83 +0.13 : Reports Q2 (Jun) earnings of $0.60 per share, $0.01 better than the First Call consensus of $0.59; revenues rose 26.4% year/year to $117.4 mln vs the $106 mln consensus. Co reaffirms guidance for FY08, sees EPS of $1.70-2.00, excluding non-recurring items, vs. $1.78 consensus. As previously reported, the Company currently estimates total capital expenditures in 2008 to be between $110.0 and $125.0 million, of which $45.0 million was the balance of the Pennsylvania Brewery purchase price paid in June 2008, and $45.0 to $55.0 million relates to capital expenditures necessary to restart and upgrade the Pennsylvania Brewery.
4:20PM Exco Resources beats by $0.09, beats on revs (XCO) : Reports Q2 (Jun) earnings of $0.34 per share, excluding non-recurring items, $0.09 better than the First Call consensus of $0.25; revenues rose 33.5% year/year to $367.5 mln vs the $322.9 mln consensus.
4:18PM Whole Foods misses by $0.07, misses on revs; guides Q4 EPS below consensus; guides FY09 EPS below consensus; increases buyback (WFMI) 22.92 +1.46 : Reports Q3 (Jun) earnings of $0.24 per share, $0.07 worse than the First Call consensus of $0.31; revenues rose 21.6% year/year to $1.84 bln vs the $1.91 bln consensus. The co estimates the negative impact on net income from Wild Oats was approximately $4.9 mln, or $0.03 per diluted share, in the quarter. Co issues downside guidance for Q4, sees EPS of $0.13-0.15 vs. $0.27 consensus. Co issues downside guidance for FY09, sees EPS of $1.08-1.14 vs. $1.52 consensus. The co expects EBITDA of $98-102 mln for the fourth quarter, resulting in a range of $501-505 mln for the fiscal year. "Our business model has been highly successful, and we remain very bullish on our growth prospects as the market for natural and organic products continues to grow and as our company continues to evolve; however, the challenging economic environment appears to be negatively impacting our sales... This, combined with our commitment to maintaining financial flexibility and investing prudently in our long-term growth, has led us to take a more conservative approach to our growth and business strategy over the short term." Additionally, the Board of Directors has increased the Company's stock repurchase authorization by $100 mln, bringing the total current authorization to $200 million.
4:14PM NetSuite reports Q2 in-line; guides Q3 in-line; guides FY08 EPS below consensus, revs in-line (N) : Reports Q2 (Jun) loss of $0.01 per share, excluding non-recurring items, in-line with the First Call consensus of ($0.01); revenues rose 43.5% year/year to $36.6 mln vs the $36.6 mln consensus. Co issues in-line guidance for Q3, sees EPS of ($0.02)-(0.01) vs. ($0.01) consensus; sees Q3 revs of $40.0-40.7 mln vs. $40.87 mln consensus. Co issues mixed guidance for FY08, sees EPS of ($0.06)-(0.04) vs. ($0.03) consensus; sees FY08 revs of $156-159 mln vs. $157.11 mln consensus.
4:12PM Cisco Systems beats by $0.01, reports revs in-line (CSCO) 22.45 +0.46 : Reports Q4 (Jul) earnings of $0.40 per share, excluding non-recurring items, $0.01 better than the First Call consensus of $0.39; revenues rose 9.9% year/year to $10.36 bln vs the $10.31 bln consensus. "Cisco delivered solid quarterly and annual results as network-enabled business process changes and productivity increases gain traction on a global basis. Today's strong results demonstrate the company's ability to execute. The market is clearly in transition, and we will use this time as an opportunity to expand our share of customer spend and to aggressively move into market adjacencies. Our focus is on our portfolio approach to technology innovation, a broad global footprint, and management dedicated to sustainable differentiation and execution. We believe we are entering the next phase of the Internet as growth and productivity will center on collaboration enabled by networked Web 2.0 technologies."
4:12PM Forest Oil beats by $0.03, beats on revs (FST) 53.72 +0.78 : Reports Q2 (Jun) earnings of $1.54 per share, $0.03 better than the First Call consensus of $1.51; revenues rose 102.8% year/year to $515.2 mln vs the $456.1 mln consensus. Co says guidance represents expected capital expenditures of $1.15 to $1.25 bln and the effects of property dispositions that have already occurred. Oil and Gas Net Sales Volumes: As a result of Forest's sale of 4 MMcfe/d of producing properties, Forest expects total net sales volumes of 188 - 192 Bcfe in 2008. Forest estimates its net sales volumes will average 525 to 535 MMcfe/d in the third quarter of 2008 and 540 to 555 MMcfe/d in the fourth quarter of 2008. Co says based on current prices, Forest expects the natural gas price differential for the remainder of 2008 will average $1.50 to $1.75 per MMbtu less than the NYMEX Henry Hub price. Based on current prices, Forest expects the oil and condensate differential for the remainder of 2008 will average $4.00 to $6.00 per Bbl less than the NYMEX West Texas Intermediate price.
4:11PM Arena Pharm misses by $0.15, misses on revs (ARNA) 6.65 +0.07 : Reports Q2 (Jun) loss of $0.89 per share, $0.15 worse than the First Call consensus of ($0.74). ARNA also reported that it updated its financial guidance for 2008 expenses for external clinical and preclinical study fees and expenses to approx $130 to $138 mln from $114 to $124 mln.
4:11PM Centillium beats by $0.02, beats on revs (CTLM) 0.72 +0.02 : Reports Q2 (Jun) loss of $0.09 per share, $0.02 better than the First Call single estiamte of ($0.11); revenues rose 2.6% year/year to $6.3 mln vs the $6.2 mln single estimate. "We recently announced that we have entered into a definitive agreement to be acquired by TranSwitch Corporation and the transaction is expected to close during the fourth quarter of 2008," said Faraj Aalaei, co-founder and CEO. "We are excited about this partnership, and we believe that the combined company will be a strong leader in the communications IC sector. We also believe that this partnership will lead to exciting new opportunities for our Optical and VoIP businesses, and enable the combined company to better serve its customers and increase shareholder value."
4:10PM priceline.com beats by $0.14, beats on revs; guides Q3 EPS in-line; raises FY08 EPS guidance (PCLN) 117.20 +5.48 : Reports Q2 (Jun) earnings of $1.55 per share, $0.14 better than the First Call consensus of $1.41; revenues rose 44.4% year/year to $514 mln vs the $495.7 mln consensus. Q2 gross travel bookings increased 70.9% y/y vs. co's guidance of 65%-75%; intl gross travel bookings increased 80.1% y/y vs. co's guidance of 80%-90%. Co issues in-line guidance for Q3, sees EPS of $2.00-2.15 vs. $2.05 consensus. Co sees Q3 year-over-year increase in gross travel bookings of ~44%-54%, with intl gross travel bookings of ~58%-68%. Co raises guidance for FY08, sees EPS of $5.50-5.85 vs. $5.54 consensus, up from prior guidance of $5.25 to $5.65. "Economic uncertainty and high fuel prices are affecting the broad travel market and significant airline capacity reductions in the fall will also have a negative impact. Through the first half of the year, we believe that the positive trends impacting our domestic and international businesses have overshadowed these negative influences. We believe these trends position us for attractive top line and earnings growth for the balance of the year and beyond."
4:08PM TechTeam misses by $0.07, beats on revs (TEAM) 9.53 -0.08 : Reports Q2 (Jun) earnings of $0.12 per share, excluding $3.9 mln restructuring charge, $0.07 worse than the 1 analyst estimate of $0.19; revenues rose 29.3% year/year to $67.9 mln vs the $67.1 mln 1 analyst estimate.
4:08PM Medicis beats by $0.05, reports revs in-line; guides Q3 EPS below consensus, revs in-line; guides Q4 (Dec) EPS in-line, revs in-line (MRX) 19.84 +0.78 : Reports Q2 (Jun) earnings of $0.40 per share, $0.05 better than the First Call consensus of $0.35; revenues rose 21.7% year/year to $132.5 mln vs the $132.7 mln consensus. Co issues mixed guidance for Q3, sees EPS of $0.24-0.27 vs. $0.29 consensus; sees Q3 revs of $132-135 mln vs. $133.67 mln consensus. Co issues in-line guidance for Q4 (Dec), sees EPS of $0.30-0.33 vs. $0.33 consensus; sees Q4 (Dec) revs of $134-137 mln vs. $136.47 mln consensus.
4:07PM Blue Nile beats by $0.03, misses on revs; guides Q3 EPS below consensus (NILE) 39.52 +0.74 : Reports Q2 (Jun) earnings of $0.20 per share, $0.03 better than the First Call consensus of $0.17; revenues rose 2.2% year/year to $73.7 mln vs the $74.5 mln consensus. Co issues for Q3 below consensus, sees EPS of $0.15-0.17 vs. $0.18 consensus. Our expectation for net sales and non-GAAP adjusted EBITDA is mid-single digit percentage growth for the year, previous guidance was 5-10%.
4:06PM Pacer Intl beats by $0.03, beats on revs (PACR) 24.08 +0.78 : Reports Q2 (Jun) earnings of $0.40 per share, $0.03 better than the First Call consensus of $0.37; revenues rose 9.2% year/year to $518.4 mln vs the $505.7 mln consensus.
4:05PM Synchronoss Tech misses by $0.01, misses on revs (SNCR) 12.35 +0.18 : Reports Q2 (Jun) earnings of $0.08 per share, excluding non-recurring items, $0.01 worse than the First Call consensus of $0.09; revenues fell 22.4% year/year to $24.3 mln vs the $24.6 mln consensus.
4:03PM Bidz.com beats by $0.04, beats on revs; guides Q3 EPS in-line, revs above consensus; raises FY08 EPS in-line, revs above consensus (BIDZ) 9.25 +0.04 : Reports Q2 (Jun) earnings of $0.14 per share, $0.04 better than the First Call consensus of $0.10; revenues rose 40.7% year/year to $55 mln vs the $49.4 mln consensus. Co issues in-line EPS guidance for Q3, sees EPS of $0.10-0.11 vs. $0.10 consensus; sees Q3 revs of $55-58 mln vs. $48.32 mln consensus. Co raises FY08 guidance, raises EPS to $0.56-0.59 vs. $0.57 consensus, up from $0.52-0.55; rasies FY08 revs to $240-245 mln vs. $234.24 mln consensus, up from $225-230 mln.
4:03PM Bio-Rad Labs beats by $0.50, beats on revs (BIO) 92.13 +1.71 : Reports Q2 (Jun) earnings of $1.58 per share, $0.50 better than the First Call consensus of $1.08; revenues rose 33.4% year/year to $452.4 mln vs the $422.9 mln consensus.
4:03PM WebMD Health beats by $0.02, reports revs in-line; reaffirms FY08 revs guidance (WBMD) 24.84 -1.03 : Reports Q2 (Jun) earnings of $0.11 per share, $0.02 better than the First Call consensus of $0.09; revenues rose 15.4% year/year to $89.2 mln vs the $89.1 mln consensus. Co reaffirms guidance for FY08, sees FY08 revs of $380-395 mln vs. $382.42 mln consensus.
4:02PM Allscripts beats by $0.02, beats on revs (MDRX) 12.39 +0.39 : Reports Q2 (Jun) earnings of $0.13 per share, excluding non-recurring items, $0.02 better than the First Call consensus of $0.11; revenues rose 16.4% year/year to $81.5 mln vs the $76.9 mln consensus.
4:02PM Onyx Pharma beats by $0.08, beats on revs (ONXX) 39.84 -0.11 : Reports Q2 (Jun) earnings of $0.15 per share, excluding non-recurring items, $0.08 better than the First Call consensus of $0.07; revenues rose 302.7% year/year to $30.2 mln vs the $24.8 mln consensus. Global Nexavar net sales, as reported by Bayer, were $168.5 mln for the quarter ended June 30, 2008, a 107% increase. "We are pleased with the strong revenues and continued momentum for Nexavar globally with net sales reaching $168.5 million in the second quarter, indicating expanding global demand for the brand. Based on a series of rolling launches worldwide, we expect to see additional growth opportunities for Nexavar, particularly for the treatment of liver cancer..."
4:02PM Ruths Chris Steak House misses by $0.05, misses on revs; guides FY08 EPS in-line (RUTH) 5.18 : Reports Q2 (Jun) earnings of $0.12 per share, excluding non-recurring items, $0.05 worse than the First Call consensus of $0.17; revenues rose 37.9% year/year to $108.1 mln vs the $110.4 mln consensus. Co issues in-line guidance for FY08, sees EPS of $0.55-0.60 vs. $0.57 consensus.
11:05AM Sun Hydraulics beats by $0.04, reports revs in-line; guides Q3 EPS below consensus, revs below consensus (SNHY) 35.15 -3.28 : As mentioned at 11:02, SNHY reported Q2 (Jun) earnings of $0.54 per share, $0.04 better than the First Call consensus of $0.50; revenues rose 18.8% year/year to $51.6 mln vs the $51.4 mln consensus. Co issues downside guidance for Q3, sees EPS of $0.35-0.37 vs. $0.42 consensus; sees Q3 revs of $45 mln vs. $47.93 mln consensus. "Sun's products are used in diversified equipment markets around the globe. Many of these markets, such as mining and energy, remain strong and demand is high. In other more obvious markets, such as equipment used in residential and commercial construction, we have begun to see some softening. The diversity of our end markets, both geographically and the segments we participate in, is pivotal to maintaining our growth."
8:35AM MGM Mirage misses by $0.02, reports revs in-line (MGM) : Reports Q2 (Jun) earnings of $0.40 per share, $0.02 worse than the First Call consensus of $0.42; revenues fell 2.1% year/year to $1.9 bln vs the $1.89 bln consensus. Casino revenue decreased 4%, mainly due to a decrease in table games volume of 7%. The table games hold percentage was at the mid-point of the normal 18% to 22% range in the current quarter and slightly higher than in the 2007 quarter. Slots revenue decreased 2% in the quarter, with the Company's Las Vegas Strip resorts posting a 10% decrease. However, slots revenue increased in the high single digits at Beau Rivage and Gold Strike Tunica and 18% at MGM Grand Detroit. MGM Grand Detroit continues to gain market share as a result of its upgraded amenities. Rooms revenue decreased 6%, with a 5% decline in Las Vegas Strip REVPAR. Average room rates were down 5% at the Company's Las Vegas Strip resorts. Las Vegas Strip occupancy decreased slightly, and the Company had approximately 32,000 less rooms available at its Las Vegas Strip resorts, mainly due to the lower room count at Monte Carlo. MGM Grand Macau, of which the Company owns 50%, recorded Property EBITDA of $23 million and an operating loss of $5 million. The Company recognized its share of MGM Grand Macau's results as follows: $4 million of loss in the "Income from unconsolidated affiliates" line and $3 million of expense in "Non-operating items from unconsolidated affiliates."
8:34AM Molson Coors Brewing misses by $0.23, reports revs in-line (TAP) 54.43 : Reports Q2 (Jun) earnings of $0.93 per share, excluding non-recurring items, $0.23 worse than the First Call consensus of $1.16; revenues rose 4.8% year/year to $1.76 bln vs the $1.76 bln consensus. "Our financial performance in the second quarter benefited from another exceptional quarter by our U.S. business, with gains in sales volume, pricing and underlying income. We are excited about this strong momentum as we launch MillerCoors. Across our company, our top brands continue to outperform the industry in the second quarter, and we achieved net pricing gains and substantial cost savings in each of our core markets. At the same time, however, energy and commodity inflation has become a bigger challenge for our company and for the global beer industry. This cost inflation, combined with our higher tax rate, drove lower after-tax income for our total company in the quarter. In the face of challenging economic conditions, we continue to implement value-adding strategies that will allow us to build our brands, achieve positive pricing, reduce costs, and grow profits and cash for our shareholders. The fundamentals of our business remain strong, and we are more excited than ever about the future for Molson Coors Brewing Company, as we strive to become a top-performing global brewer."
8:28AM 3Com raises Q1 guidance above consensus (COMS) 1.86 : As mentioned at 8:25, co issues upside guidance for Q1 (Aug), sees EPS of $0.06-0.08 vs. $0.04 First Call consensus, prior guidance $0.03-0.05; sees Q1 (Aug) revs of $335-340 mln vs. $327.72 mln consensus, prior guidance $325-330 mln.
8:27AM Wilson Greatbatch beats by $0.06, beats on revs (GB) 20.40 : Reports Q2 (Jun) earnings of $0.30 per share, excluding non-recurring items, $0.06 better than the First Call consensus of $0.24; revenues rose 80.4% year/year to $141.6 mln vs the $128.6 mln consensus. "We are in the early stages of a two-year plan to recognize the synergies from recent acquisitions. This quarter we grew operating margins through sales growth as well as cost reduction initiatives. Going forward, investors should expect to see both top line growth through the introduction of new product technologies to current and new customers, and bottom line growth as we diligently undertake further consolidation and integration efforts."
8:06AM Almost Family beats by $0.12, beats on revs (AFAM) 33.57 : Reports Q2 (Jun) earnings of $0.50 per share, $0.12 better than the First Call consensus of $0.38; revenues rose 49.8% year/year to $48.7 mln vs the $41.9 mln consensus. "... We're reporting record revenues and earnings, a continuation of our aggressive growth strategy and the achievement of numerous capital market milestones. I couldn't be more pleased with our financial report for the second quarter, in particular with our 33% organic revenue growth rate in our Visiting Nurse (VN) segment. Total revenue growth in the VN segment, where we focus most of our effort, was 66% over the same quarter last year and 30% over the first quarter of 2008..."
8:05AM Bill Barrett beats by $0.12, beats on revs; increases production guidance (BBG) 38.99 : Reports Q2 (Jun) earnings of $0.75 per share, $0.12 better than the First Call consensus of $0.63; revenues rose 56.5% year/year to $157.5 mln vs the $152.2 mln consensus. "We are raising our '08 production estimate range to 77 - 80 Bcfe from its prior estimate of 74 - 78 Bcfe. We also anticipate an increase in capital expenditures to $625 - $650 million, up $50 million, which will include increased 2008 drilling at our Piceance and West Tavaputs projects. And, we are achieving lower lease operating expenses and have reduced the estimated cost per Mcfe to $0.62 - $0.65 from $0.64 - $0.68."
8:01AM Rowan Cos beats by $0.01, beats on revs (RDC) 37.71 : Reports Q2 (Jun) earnings of $1.05 per share, excluding non-recurring items, $0.01 better than the First Call consensus of $1.04; revenues rose 15.8% year/year to $587.1 mln vs the $564.3 mln consensus.
7:48AM Brinker beats by $0.08, beats on revs (EAT) 18.13 : Reports Q4 (Jun) earnings of $0.50 per share, excluding non-recurring items, $0.08 better than the First Call consensus of $0.42; revenues fell 6.1% year/year to $1.07 bln vs the $932.4 mln consensus. Co sees Y09 EPS growth of 8-10%, co sees rev growth of 2.5-3.5%, both excluding Macaroni Grill. Co sees Y09 comparable restaurant sales growth of 1.5-2.5%.
7:08AM Transdigm Group beats by $0.05, beats on revs; guides FY08 EPS above consensus, revs in-line (TDG) 37.88 : Reports Q3 (Jun) earnings of $0.75 per share, excluding non-recurring items, $0.05 better than the First Call consensus of $0.70; revenues rose 18.0% year/year to $186 mln vs the $182 mln consensus. Co issues guidance for FY08, sees EPS of $2.75-2.79 vs. $2.74 consensus; sees FY08 revs of $710-715 mln vs. $711.78 mln consensus.
7:07AM Marvel Enterprises beats by $0.14, beats on revs (MVL) 35.26 : Reports Q2 (Jun) earnings of $0.59 per share, $0.14 better than the First Call consensus of $0.45; revenues rose 54.6% year/year to $156.9 mln vs the $131 mln consensus. Co issues guidance for FY08, sees EPS of $1.55-1.75, may not be comparable to $1.96 consensus; sees FY08 revs of $450-480 mln, may not be comparable to $543.12 mln consensus. Marvel has now included revenues and expenses from its self-produced feature films Iron Man and The Incredible Hulk in its financial guidance. Marvel's previous guidance excluded feature film contributions. Marvel's updated guidance also reflects a modest increase in full year contributions from its licensing segment and slightly reduced operating income expectations from publishing.
7:07AM Duke Energy beats by $0.02, beats on revs (DUK) 17.37 : Reports Q2 (Jun) earnings of $0.27 per share, excluding non-recurring items, $0.02 better than the First Call consensus of $0.25; revenues rose 8.9% year/year to $3.23 bln vs the $3.15 bln consensus.
7:06AM Dollar Thrifty beats by $0.18, reports revs in-line (DTG) 3.19 : Reports Q2 (Jun) loss of $0.23 per share, $0.18 better than the First Call consensus of ($0.41); revenues fell 1.3% year/year to $445.7 mln vs the $448.4 mln consensus. 'The company expects the operating conditions to remain challenging due to concerns about the strength of the economy, volatility in used car pricing, credit markets and reduced airline capacity. "In this tough economic environment, we continue to concentrate on the items in our business that we control such as maximizing revenue per day, vehicle utilization, cost reduction and service delivery," said Mr. Paxton. "Our focus in today's environment is on executing every day, in every market, with every customer."... The Company announced that it is modifying its earnings guidance policy given the lack of visibility in the current operating environment and a desire to focus on longer term business strategies. The co will no longer provide annual earnings per share or annual Corporate EBITDA guidance...'
7:04AM Procter & Gamble beats by $0.02, beats on revs; guides Q1 EPS in-line (PG) 65.82 : Reports Q4 (Jun) earnings of $0.80 per share, excluding non-recurring items, $0.02 better than the First Call consensus of $0.78; revenues rose 10.3% year/year to $21.27 bln vs the $21.05 bln consensus. Co issues in-line guidance for Q1, sees EPS of $0.98-1.00 vs. $1.00 consensus. "For Q1, the co expects organic sales to increase 4-6%. Organic volume is expected to grow 2-3% and the combination of pricing and product mix is expected to add 2-3%. In addition, foreign exchange is forecast to add approximately 4-5%, and the net impact of acquisitions and divestitures is estimated to reduce sales growth by about 1%. Total sales are expected to increase 7-10%."
7:03AM Emergency Medical Services beats by $0.04, reports revs in-line; guides FY08 EPS above consensus (EMS) 26.80 : Reports Q2 (Jun) earnings of $0.43 per share, $0.04 better than the First Call consensus of $0.39; revenues rose 10.5% year/year to $571.1 mln vs the $567 mln consensus. Co issues upside guidance for FY08, sees EPS of $1.70-1.75 vs. $1.62 consensus, up from previously announced guidance of $1.57 to $1.63. FY08 adjusted EBITDA guidance is updated to an expected range of $227-232 mln from previously announced guidance of $225-$230 mln.
7:00AM II-VI Inc beats by $0.07, beats on revs; guides Q1 EPS above consensus, revs above consensus; guides FY09 EPS above consensus, revs above consensus (IIVI) 37.15 : Reports Q4 (Jun) earnings of $0.50 per share, $0.07 better than the First Call consensus of $0.43; revenues rose 31.5% year/year to $91.8 mln vs the $86.8 mln consensus. Co issues upside guidance for Q1, sees EPS of $0.41-0.44 vs. $0.39 consensus; sees Q1 revs of $84-86 mln vs. $81.37 mln consensus. Co issues upside guidance for FY09, sees EPS of $1.75-1.80 vs. $1.74 consensus; sees FY09 revs of $347-352 mln vs. $346.44 mln consensus.
6:46AM Emerson beats by $0.01, beats on revs; guides FY08 EPS in-line, revs in-line (EMR) 47.83 : Reports Q3 (Jun) earnings of $0.82 per share, $0.01 better than the First Call consensus of $0.81; revenues rose 13.8% year/year to $6.57 bln vs the $6.41 bln consensus. Co issues in-line guidance for FY08, sees EPS of $3.05-3.10 vs. $3.09 consensus; sees FY08 revs of ~$25 bln vs. $24.71 bln consensus.
6:11AM Pediatrix Medical beats by $0.02, beats on revs; guides Q3 & Q4 EPS in-line (PDX) 48.73 : Reports Q2 (Jun) earnings of $0.80 per share, $0.02 better than the First Call consensus of $0.78; revenues rose 15.4% year/year to $257.7 mln vs the $248.5 mln consensus. Co issues in-line guidance for Q3, sees EPS of $0.84-0.87 vs. $0.86 consensus. Co issues in-line guidance for Q4 (Dec), sees EPS of $0.84-0.87 vs. $0.87 consensus.
6:08AM W&T Offshore beats by $0.02, beats on revs (WTI) 42.60 : Reports Q2 (Jun) earnings of $1.86 per share, excluding non-recurring items, $0.02 better than the First Call consensus of $1.84; revenues rose 69.1% year/year to $461 mln vs the $433 mln consensus. Co is revising its 2008 well count from 50 to a range of between 30 to 35 wells.
6:01AM Covidien beats by $0.06, beats on revs (COV) 49.90 : Reports Q3 (Jun) earnings of $0.72 per share, excluding non-recurring items, $0.06 better than the First Call consensus of $0.66; revenues rose 14.4% year/year to $2.6 bln vs the $2.49 bln consensus.
12:51AM MicroStrategy misses by $0.42, beats on revs (MSTR) 60.12 : Reports Q2 (Jun) earnings of $0.66 per share, excluding discontinued operations, $0.42 worse than the First Call consensus of $1.08.
No comments:
Post a Comment